---
title: "Triflupromazine - Psychotic disorder - 2"
sidebar: mydoc_sidebar
permalink: db00508-mesh-d011618-2.html
toc: false 
---


Path ID: `DB00508_MESH_D011618_2`
{% include image.html url="images/db00508-mesh-d011618-2.png" file="db00508-mesh-d011618-2.png" alt="db00508-mesh-d011618-2" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D014273 | triflupromazine | Drug |
| UniProt:P14416 | dopamine D2 receptor | Protein |
| UBERON:0001017 | central nervous system | GrossAnatomicalStructure |
| HP:0008760 | violent behavior | PhenotypicFeature |
| MESH:D011618 | psychotic disorders | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Triflupromazine | DECREASES ACTIVITY OF | Dopamine D2 Receptor |
| Dopamine D2 Receptor | LOCATED IN | Central Nervous System |
| Central Nervous System | PREVENTS | Violent Behavior |
| Violent Behavior | CORRELATED WITH | Psychotic Disorders |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB00508#mechanismofaction](https://go.drugbank.com/drugs/DB00508#mechanismofaction)
